Natco Pharma

Price chart

Previous close

₹805.05

Open

₹807.00

Day high

₹822.80

Day low

₹802.00

Listed on NSE since 27 December 1995.

Market value

₹15,831 Cr

P/E (trailing)

12.73

EPS (trailing)

₹63.37

Price to book

1.57

Dividend yield

0.74%

Debt to equity

0.08

Profit margin

32.8%

Beta

0.18

Volume today

2.90 L

Average volume

4.82 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Natco Pharma’s results filed with NSE, consolidated (the whole group). Net profit is the share of Natco Pharma’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Natco Pharma’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Agrochemicals. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, fungicides, herbicides, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Hyderabad

Employees

4,433

Company website · Profile: Yahoo Finance

No headlines name Natco Pharma in the last day or two.

• Rights 2:21 @ Premium Rs 748/-

  Right · ex-date 1 October 2026

• Interim Dividend - Rs 1.50 Per Share

  Dividend · ex-date 20 August 2026

• Interim Dividend - Rs 1.50 Per Share

  Dividend · ex-date 18 February 2026

• Interim Dividend - Rs 1.50 Per Share

  Dividend · ex-date 20 November 2025

• Interim Dividend - Rs 2 Per Share

  Dividend · ex-date 19 August 2025

• Interim Dividend - Rs 1.50 Per Share

  Dividend · ex-date 18 February 2025

• Interim Dividend - Rs 1.50 Per Share

  Dividend · ex-date 27 November 2024

• Annual General Meeting

  Action · ex-date 25 September 2024

Source: NSE. Latest first, 8 of 20.